Health
Merck’s Ebola Vaccine Study Supports DRC Outbreak Testing
New data supports the use of Merck’s Ebola vaccine Ervebo in the Democratic Republic of Congo (DRC) outbreak, suggesting it could offer some protection against another strain.
Coverage timeline — 1 article
STAT News
New data supports the idea that Merck’s Ebola vaccine Ervebo, licensed to target the Zaire species of ebolaviruses, could also offer some protection against another.
2026-07-22 21:00 UTC